CLINICAL_TRIALS
trial_result
· 2024-08-15
Clinical Trial Update: An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options [Phase 3]
Summary
Phase 3 expanded-access trial of spesolimab in Japan for flare-ups of generalized pustular psoriasis, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Generalized Pustular Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2024-08-15